Preparing your Shotlee experience
As the holiday season approaches, many individuals express concerns regarding potential weight gain. Prestige Men's Health in Holladay is offering medically supervised weight-loss programs using GLP-1 treatments like semaglutide, providing screening, labs, and continuous monitoring. This comes as more Utah residents seek medical guidance for weight management during this time.
With office parties, family gatherings, and numerous food-centric celebrations, gaining weight during the holiday season can seem unavoidable. For many, the anxiety surrounding this potential weight gain begins even before New Year's resolutions are made.
Clinicians at Prestige Men's Health in Holladay note that the annual trend of holiday weight gain is a factor driving increased interest in semaglutide, a GLP-1 prescription medication utilized in their medically supervised weight-loss programs.
Dr. Joshua Schmidt, M.D., founder of the clinic, stated that they have broadened their services to include supervised weight loss treatments. The clinic is also known for men's health services such as Low T and erectile dysfunction treatment.
Dr. Schmidt explained, "Our decision to concentrate on these treatments is directly related to the rise of these innovative weight-loss protocols." These protocols encompass semaglutide-based drugs such as Ozempic and Wegovy, in addition to Mounjaro and Zepbound, which utilize tirzepatide, a different GLP-1 class compound.
According to Dr. Schmidt, both semaglutide and tirzepatide facilitate weight loss and blood-sugar regulation by slowing gastric emptying, resulting in prolonged satiety and decreased appetite. These injectables also stimulate receptors in the brain and pancreas, further reducing hunger. Health tracking apps like Shotlee can help monitor progress and side effects during such treatments.
While some individuals may experience manageable, primarily stomach-related side effects like nausea, constipation, or diarrhea that typically diminish over time, more serious complications are outlined in boxed warnings for GLP-1 based medicines, including a rare thyroid C-cell tumor risk observed in animal studies. Therefore, doctors will not prescribe them to individuals with certain thyroid cancer histories, something that is closely monitored.
Dr. Schmidt noted that the seasonal demand for weight loss solutions begins with Thanksgiving and continues through Christmas and New Year's. He also states that weight control is a year-round endeavor, and for many, it presents a significant challenge. He adds that supervised treatment options, when combined with diet and exercise, can promote clinically significant weight loss for suitable patients.
The clinic aims to provide transparent and predictable pricing. Prestige Men's Health provides complimentary consultations to assess a patient's eligibility for medication-based weight management. Initial lab work typically costs around $30. Continuous care is approximately $80 per month, with multi-month plans averaging about $70 per month, depending on the chosen plan.
To qualify, patients must undergo a medical assessment and lab testing before commencing medication, with continuous monitoring throughout the treatment period.
According to Dr. Schmidt, these medications are not a quick fix, but rather tools that are most effective when integrated into a comprehensive plan.
Dr. Schmidt emphasized that GLP-1 medications are not suitable for everyone. FDA prescribing guidelines for semaglutide and tirzepatide specify medical screening requirements, gradual dosing regimens, and the necessity for ongoing monitoring.
Potential side effects can include digestive issues, and prescribing labels caution against rarer but more severe risks. Patients should discuss their medical history with a licensed healthcare professional before initiating any prescription weight-loss medication.
Most patients begin with either an in-person or telehealth consultation. If eligible, lab testing is scheduled before starting medication. Telehealth weight-loss consultations are available for qualifying patients throughout Utah, including Salt Lake County and the Wasatch Front, as well as licensed neighboring states. Labs are conducted locally, and medications are supplied via shipment or a local pharmacy, when appropriate.
GLP-1 medications are prescription drugs designed to regulate appetite and blood sugar levels. They can aid in weight loss when used under the guidance of a healthcare professional.
No. Semaglutide and other GLP-1 medications have specific eligibility criteria and potential side effects. A clinician must assess a patient's suitability for the medication.
Results can vary. Clinical trials indicate average weight-loss outcomes, but individual results may depend on factors such as medical history, dosage, and lifestyle.
No. Telehealth consultations are available for eligible patients throughout Utah and in appropriately licensed states.
⚠️ Disclaimer: This article is for informational purposes only. Consult your healthcare provider before starting any medication or supplement.
Original content from Gephardt Daily
View Original Article
Mounjaro, a drug by Eli Lilly, is set to be added to China's state health insurance on January 1st. This inclusion could intensify competition among pharmaceutical companies. The move aims to improve access for China's large population.
Urban elites are currently the main drivers behind the increasing popularity of GLP-1 weight loss medications. Changes in distribution strategies and price adjustments could potentially transform this trend. These factors could democratize access to these treatments.
An ITV presenter, known for her financial expertise on Lorraine, has publicly discussed her weight loss journey. She attributes her four-stone weight loss to the use of Mounjaro, resulting in a significant change in her dress size.
Monitor GLP-1 medications, peptide therapy, weight loss, and wellness metrics with our comprehensive health tracking app. Join thousands of users taking control of their health!
Start Tracking Free Forever! ✨